New insights into the steen solution properties: Breakthrough in antioxidant effects via NOX2 downregulation

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Carnevale, Roberto ^a   Biondi Zoccai, Giuseppe ^a   Peruzzi, Mariangela ^a   De Falco, Elena ^a   Chimenti, Isotta ^a   Venuta, Federico ^a,b   Anile, Marco ^a   Diso, Daniele ^a   Cavarretta, Elena ^a   Marullo, Antonino G M ^a   Sartini, Patrizio ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a   Frati, Giacomo ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Eleonora Lonillard Spencer Cenci Foundation   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; NITRIC OXIDE; PLATELETS;

ANTIOXIDANT EFFECT; ANTIOXIDANT MOLECULES; ANTIOXIDANT PROPERTIES; BUFFER SOLUTIONS; CELL INCUBATION; CELL STIMULATION; HEALTHY VOLUNTEERS; SOLUTION PROPERTY;

ANTIOXIDANTS;

ANTIOXIDANT; BUFFER; ISOPROSTANE DERIVATIVE; NITRIC OXIDE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; VASODILATOR AGENT; 8-EPI-PROSTAGLANDIN F2ALPHA; ACETOPHENONE DERIVATIVE; APOCYNIN; CYBB PROTEIN, HUMAN; DEXTRAN; ISOTONIC SOLUTION; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; PROSTAGLANDIN F2 ALPHA; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL MEMBRANE; CELL STIMULATION; CHEMICAL PHENOMENA; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG PARENCHYMA; MALE; NORMAL HUMAN; OXIDATIVE STRESS; SOLUTION AND SOLUBILITY; STEEN SOLUTION; THROMBOCYTE; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLISM;

ACETOPHENONES; ADULT; ANTIOXIDANTS; BLOOD PLATELETS; DEXTRANS; DINOPROST; DOWN-REGULATION; FEMALE; HUMANS; ISOPROSTANES; ISOTONIC SOLUTIONS; LEUKOCYTES; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN;

EID: 84900316322     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/242180     Document Type: Article

References (19)

1. Maurer J. R., Frost A. E., Estenne M., Higenbottam T., Glanville A. R., International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. The Journal of Heart and Lung Transplantation 1998 17 7 703 709 2-s2.0-0032109619
2. Christie J. D., Edwards L. B., Kucheryavaya A. Y., Benden C., Dobbels F., Kirk R., Rahmel A. O., Stehlik J., Hertz M. I., The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report-2011. Journal of Heart and Lung Transplantation 2011 30 10 1104 1122 2-s2.0-80053316665 10.1016/j.healun.2011. 08.004
3. Kawut S. M., Reyentovich A., Wilt J. S., Anzeck R., Lederer D. J., O'Shea M. K., Sonett J. R., Arcasoy S. M., Outcomes of extended donor lung recipients after lung transplantation. Transplantation 2005 79 3 310 316 2-s2.0-14544277231 10.1097/01.TP.0000149504.53710.AE (Pubitemid 40299537)
4. Ingemansson R., Eyjolfsson A., Mared L., Pierre L., Algotsson L., Ekmehag B., Gustafsson R., Johnsson P., Koul B., Lindstedt S., Lührs C., Sjöberg T., Steen S., Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Annals of Thoracic Surgery 2009 87 1 255 260 2-s2.0-57649237744 10.1016/j.athoracsur.2008.09.049
5. de Meester J., Smits J. M. A., Persijn G. G., Haverich A., Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. Journal of Heart and Lung Transplantation 2001 20 5 518 524 2-s2.0-0035043334 10.1016/S1053-2498(01) 00241-8 (Pubitemid 32410013)
6. Abecassis M., Bridges N. D., Clancy C. J., Solid-organ transplantation in older adults: current status and future research. The American Journal of Transplantation 2012 12 10 2608 2622
7. Date H., Shiraishi T., Sugimoto S., Outcome of living-donor lobar lung transplantation using a single donor. The Journal of Thoracic and Cardiovascular Surgery 2012 144 3 710 715
8. Frati P., Organ transplantation from living donors, between bioethics and the law. Transplantation Proceedings 2005 37 6 2433 2435 2-s2.0-25144435594 10.1016/j.transproceed.2005.06.042 (Pubitemid 41354626)
9. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., Algotsson L., Transplantation of lungs from a non-heart-beating donor. The Lancet 2001 357 9259 825 829 2-s2.0-0035901275 10.1016/S0140-6736(00)04195-7 (Pubitemid 32239366)
10. Cypel M., Yeung J. C., Mingyao L., Anraku M., Chen F., Karolak W., Sato M., Laratta J., Azad S., Madonik M., Chow C.-W., Chaparro C., Hutcheon M., Singer L. G., Slutsky A. S., Yasufuku K., Perrot M. D., Pierre A. F., Waddell T. K., Keshavjee S., Normothermic ex vivo lung perfusion in clinical lung transplantation. The New England Journal of Medicine 2011 364 15 1431 1440 2-s2.0-79954566390 10.1056/NEJMoa1014597
11. Wallinder A., Ricksten S. E., Silverborn M., Hansson C., Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Journal of Cardiothoracic Surgery 2014 45 1 40 45
12. Pignatelli P., Carnevale R., Cangemi R., Loffredo L., Sanguigni V., Stefanutti C., Basili S., Violi F., Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 2 360 367 2-s2.0-75149178670 10.1161/ATVBAHA.109.198622
13. Fortuño A., Bidegain J., Robador P. A., Hermida J., López-Sagaseta J., Beloqui O., Díez J., Zalba G., Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension. Hypertension 2009 54 4 744 750 2-s2.0-70349659198 10.1161/HYPERTENSIONAHA.109. 129353
14. El-Benna J., Dang P. M. C., Gougerot-Pocidalo M. A., Marie J. C., Braut-Boucher F., p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Experimental and Molecular Medicine 2009 41 4 217 225 2-s2.0-65949102522 10.3858/emm.2009.41.4. 058
15. Sugamura K., Keaney J. F. Jr., Reactive oxygen species in cardiovascular disease. Free Radical Biology and Medicine 2011 51 5 978 992 2-s2.0-80051666038 10.1016/j.freeradbiomed.2011.05.004
16. Violi F., Pignatelli P., Platelet oxidative stress and thrombosis. Thrombosis Research 2012 129 3 378 381 2-s2.0-84857792783 10.1016/j.thromres. 2011.12.002
17. Pignatelli P., Carnevale R., di Santo S., Bartimoccia S., Sanguigni V., Lenti L., Finocchi A., Mendolicchio L., Soresina A. R., Plebani A., Violi F., Inherited Human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 2 423 434 2-s2.0-79551476712 10.1161/ATVBAHA.110.217885
18. Pignatelli P., Sanguigni V., Lenti L., Ferro D., Finocchi A., Rossi P., Violi F., gp91phox-dependent expression of platelet CD40 ligand. Circulation 2004 110 10 1326 1329 2-s2.0-4444294006 10.1161/01.CIR.0000134963.77201.55 (Pubitemid 39202353)
19. Seno T., Inoue N., Gao D., Okuda M., Sumi Y., Matsui K., Yamada S., Hirata K.-I., Kawashima S., Tawa R., Imajoh-Ohmi S., Sakurai H., Yokoyama M., Involvement of NADH/NADPH oxidase in human platelet ROS production. Thrombosis Research 2001 103 5 399 409 2-s2.0-17944369584 10.1016/S0049-3848(01)00341-3 (Pubitemid 32831474)